Sheng‐Kai Wang

4.5k total citations
33 papers, 1.9k citations indexed

About

Sheng‐Kai Wang is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sheng‐Kai Wang has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Organic Chemistry and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sheng‐Kai Wang's work include Glycosylation and Glycoproteins Research (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Sheng‐Kai Wang is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Sheng‐Kai Wang collaborates with scholars based in Taiwan, United States and China. Sheng‐Kai Wang's co-authors include Chi‐Huey Wong, Pi‐Hui Liang, Tsui-Ling Hsu, Ian Parker, Marta Sanna, Sindy H. Wei, Michael D. Cahalan, Euijung Jo, Melanie P. Matheu and Hugh Rosen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Sheng‐Kai Wang

33 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng‐Kai Wang Taiwan 16 1.5k 729 304 302 218 33 1.9k
Hubert Gaertner Switzerland 23 1.2k 0.8× 418 0.6× 239 0.8× 256 0.8× 78 0.4× 55 1.7k
Jon R. Appel United States 19 2.1k 1.4× 549 0.8× 198 0.7× 739 2.4× 167 0.8× 46 2.6k
Sophie Faure France 26 1.2k 0.8× 983 1.3× 330 1.1× 102 0.3× 58 0.3× 69 2.0k
Jacqui Méndez United States 10 2.4k 1.6× 584 0.8× 126 0.4× 306 1.0× 350 1.6× 14 3.0k
Gregory H. Bird United States 32 3.5k 2.4× 701 1.0× 313 1.0× 312 1.0× 209 1.0× 59 4.1k
Shawn DeFrees United States 26 1.3k 0.9× 777 1.1× 328 1.1× 251 0.8× 134 0.6× 31 1.9k
Scott C. Garman United States 27 1.0k 0.7× 587 0.8× 675 2.2× 426 1.4× 458 2.1× 43 2.7k
Shixian Lin China 25 1.9k 1.3× 1.0k 1.4× 154 0.5× 294 1.0× 184 0.8× 52 2.5k
Macarena Sánchez‐Navarro Spain 24 1.3k 0.8× 596 0.8× 183 0.6× 223 0.7× 47 0.2× 50 2.1k
Toshiyuki Inazu Japan 26 2.5k 1.7× 1.6k 2.1× 228 0.8× 124 0.4× 255 1.2× 89 2.8k

Countries citing papers authored by Sheng‐Kai Wang

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Kai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Kai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Kai Wang more than expected).

Fields of papers citing papers by Sheng‐Kai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Kai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Kai Wang. The network helps show where Sheng‐Kai Wang may publish in the future.

Co-authorship network of co-authors of Sheng‐Kai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Kai Wang. A scholar is included among the top collaborators of Sheng‐Kai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Kai Wang. Sheng‐Kai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Chia-Lung, Je‐Wei Chang, Kum‐Yi Cheng, et al.. (2024). Comprehensive characterization of polyproline tri-helix macrocyclic nanoscaffolds for predictive ligand positioning. Nanoscale Advances. 6(3). 947–959. 2 indexed citations
2.
Xu, Buyun, Chao Xu, Yong Sun, et al.. (2022). Fixed complex electrograms during sinus rhythm and local pacing: potential ablation targets for persistent atrial fibrillation. Scientific Reports. 12(1). 10697–10697. 3 indexed citations
3.
Chen, Xiaorui, I-Ju Liu, Chun‐Mei Hu, et al.. (2022). Structural basis of interleukin-17B receptor in complex with a neutralizing antibody for guiding humanization and affinity maturation. Cell Reports. 41(4). 111555–111555. 2 indexed citations
4.
Xu, Chao, et al.. (2022). Relationship between the time point of left atrial size change and the outcomes of radiofrequency catheter ablation. Journal of Interventional Cardiac Electrophysiology. 64(3). 669–675. 3 indexed citations
5.
Liu, Yingjie, et al.. (2021). Design and synthesis of fluorinated peptides for analysis of fluorous effects on the interconversion of polyproline helices. Bioorganic Chemistry. 119. 105491–105491. 4 indexed citations
6.
Ravinder, M., Chien‐Tai Ren, Yu‐Wei Lin, et al.. (2020). Synthesis of Asymmetric N-Glycans as Common Core Substrates for Structural Diversification through Selective Enzymatic Glycosylation. ACS Chemical Biology. 15(9). 2382–2394. 14 indexed citations
7.
Tsai, Chia-Lung, et al.. (2019). Selective targeting of DC-SIGN by controlling the oligomannose pattern on a polyproline tetra-helix macrocycle scaffold. Chemical Communications. 55(62). 9124–9127. 15 indexed citations
8.
Xing, Yangbo, Buyun Xu, Xia Sheng, et al.. (2018). Transformation from persistent atrial fibrillation to paroxysmal type after initial ablation predicts success of repeated ablation. International Journal of Cardiology. 268. 120–124. 7 indexed citations
9.
Cheng, Ting-Jen Rachel, et al.. (2018). Development of Pseudomonas aeruginosa Lectin LecA Inhibitor by using Bivalent Galactosides Supported on Polyproline Peptide Scaffolds. Chemistry - An Asian Journal. 13(6). 686–700. 18 indexed citations
10.
Liu, Chun‐Hung, Fu‐Fei Hsu, Kuan‐Wei Huang, et al.. (2017). A multifunctional nanocarrier for efficient TRAIL‐based gene therapy against hepatocellular carcinoma with desmoplasia in mice. Hepatology. 67(3). 899–913. 43 indexed citations
11.
Wang, Sheng‐Kai & Chao‐Min Cheng. (2015). Glycan-based diagnostic devices: current progress, challenges and perspectives. Chemical Communications. 51(94). 16750–16762. 27 indexed citations
12.
Doores, Katie J., Michael Huber, Khoa Le, et al.. (2012). 2G12-Expressing B Cell Lines May Aid in HIV Carbohydrate Vaccine Design Strategies. Journal of Virology. 87(4). 2234–2241. 13 indexed citations
13.
Liang, C. Jason, Sheng‐Kai Wang, Chin‐Wei Lin, et al.. (2011). Effects of Neighboring Glycans on Antibody–Carbohydrate Interaction. Angewandte Chemie International Edition. 50(7). 1608–1612. 54 indexed citations
14.
Liang, C. Jason, Sheng‐Kai Wang, Chin‐Wei Lin, et al.. (2011). Effects of Neighboring Glycans on Antibody–Carbohydrate Interaction. Angewandte Chemie. 123(7). 1646–1650. 12 indexed citations
15.
Astronomo, Rena D., Eiton Kaltgrad, Andrew K. Udit, et al.. (2010). Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds. Chemistry & Biology. 17(4). 357–370. 105 indexed citations
16.
Wang, Sheng‐Kai, Pi‐Hui Liang, Rena D. Astronomo, et al.. (2008). Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proceedings of the National Academy of Sciences. 105(10). 3690–3695. 243 indexed citations
17.
Sanna, Marta, Sheng‐Kai Wang, Pedro J. Gonzalez‐Cabrera, et al.. (2006). Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chemical Biology. 2(8). 434–441. 336 indexed citations
18.
Wei, Sindy H., Hugh Rosen, Melanie P. Matheu, et al.. (2005). Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nature Immunology. 6(12). 1228–1235. 235 indexed citations
19.
Liang, Fu‐Sen, Sheng‐Kai Wang, Takuji Nakatani, & Chi‐Huey Wong. (2004). Targeting RNAs with Tobramycin Analogues. Angewandte Chemie International Edition. 43(47). 6496–6500. 25 indexed citations
20.
Liang, Fu‐Sen, Sheng‐Kai Wang, Takuji Nakatani, & Chi‐Huey Wong. (2004). Targeting RNAs with Tobramycin Analogues. Angewandte Chemie. 116(47). 6658–6662. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert Gaertner Breakdown of academic impact, for papers by Jon R. Appel Breakdown of academic impact, for papers by Sophie Faure Breakdown of academic impact, for papers by Jacqui Méndez Breakdown of academic impact, for papers by Gregory H. Bird Breakdown of academic impact, for papers by Shawn DeFrees Breakdown of academic impact, for papers by Scott C. Garman Breakdown of academic impact, for papers by Shixian Lin Breakdown of academic impact, for papers by Macarena Sánchez‐Navarro Breakdown of academic impact, for papers by Toshiyuki Inazu
Rankless by CCL
2026